Literature DB >> 7980403

Expression of mouse phosphofructokinase-M gene alternative transcripts: evidence for the conserved two-promoter system.

H Nakajima1, T Noguchi, T Hamaguchi, K Tomita, T Hanafusa, N Kono, T Tanaka, M Kuwajima, Y Matsuzawa.   

Abstract

Molecular cloning of the 5' part of mouse phosphofructokinase-M cDNA was performed. In the 46 cDNA clones isolated, there were two classes of 5' untranslated sequences. One had an EcoRI site within its 5' untranslated sequence. This showed 83.0% similarity with human type B mRNA for phosphofructokinase-M. The other lacked an EcoRI site, showing 92.9% similarity with human type C mRNA. Using the reverse-transcription PCR technique, we found that the transcript with an EcoRI site was exclusively expressed in cardiac and skeletal muscles, while that without an EcoRI site was expressed in all the mouse tissues examined. The results suggested that the mouse phosphofructokinase-M gene was transcribed through alternative splicing by the multiple promoters. This transcription mechanism was considered to be evolutionarily conserved. The level of phosphofructokinase-M gene expression in mouse cardiac and skeletal muscles decreased in the ketotic diabetic state. Although the regulatory mechanism and the physiological significance are not fully known, this would indicate that phosphofructokinase-M gene transcripts are affected during the diabetic state.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7980403      PMCID: PMC1137348          DOI: 10.1042/bj3030449

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  29 in total

Review 1.  Phosphofructokinase.

Authors:  K Uyeda
Journal:  Adv Enzymol Relat Areas Mol Biol       Date:  1979

2.  Structural analysis of the Drosophila rpA1 gene, a member of the eucaryotic 'A' type ribosomal protein family.

Authors:  S Qian; J Y Zhang; M A Kay; M Jacobs-Lorena
Journal:  Nucleic Acids Res       Date:  1987-02-11       Impact factor: 16.971

3.  Cloning of a complete protein-coding sequence of human platelet-type phosphofructokinase isozyme from pancreatic islet.

Authors:  K Eto; H Sakura; K Yasuda; T Hayakawa; E Kawasaki; R Moriuchi; S Nagataki; Y Yazaki; T Kadowaki
Journal:  Biochem Biophys Res Commun       Date:  1994-02-15       Impact factor: 3.575

Review 4.  Isozymes of phosphofructokinase.

Authors:  S Vora
Journal:  Isozymes Curr Top Biol Med Res       Date:  1982

5.  The preferential translation of Drosophila hsp70 mRNA requires sequences in the untranslated leader.

Authors:  T J McGarry; S Lindquist
Journal:  Cell       Date:  1985-10       Impact factor: 41.582

6.  A catalogue of splice junction sequences.

Authors:  S M Mount
Journal:  Nucleic Acids Res       Date:  1982-01-22       Impact factor: 16.971

7.  Phosphofructokinase: structure and control.

Authors:  P R Evans; G W Farrants; P J Hudson
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1981-06-26       Impact factor: 6.237

8.  Evolution of phosphofructokinase--gene duplication and creation of new effector sites.

Authors:  R A Poorman; A Randolph; R G Kemp; R L Heinrikson
Journal:  Nature       Date:  1984 May 31-Jun 6       Impact factor: 49.962

9.  Regulation of rat liver L-type pyruvate kinase mRNA by insulin and by fructose.

Authors:  T Noguchi; H Inoue; T Tanaka
Journal:  Eur J Biochem       Date:  1982-11-15

10.  Insulin-mediated regulation of heart atrial and ventricular 6-phosphofructo-1-kinase.

Authors:  G A Dunaway; T P Kasten; D Naqui
Journal:  J Biol Chem       Date:  1986-06-15       Impact factor: 5.157

View more
  3 in total

1.  Alteration of the levels of the M-type 6-phosphofructo-1-kinase mRNA isoforms during neonatal maturation of heart, brain and muscle.

Authors:  Y Mhaskar; G Armour; G Dunaway
Journal:  Mol Cell Biochem       Date:  2000-11       Impact factor: 3.396

2.  Missense mutation in PFKM associated with muscle-type phosphofructokinase deficiency in the Wachtelhund dog.

Authors:  G Inal Gultekin; K Raj; S Lehman; A Hillström; U Giger
Journal:  Mol Cell Probes       Date:  2012-03-16       Impact factor: 2.365

3.  Posttranslational modification of 6-phosphofructo-1-kinase as an important feature of cancer metabolism.

Authors:  Andreja Šmerc; Eva Sodja; Matic Legiša
Journal:  PLoS One       Date:  2011-05-04       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.